ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IVX Innosis Ecological Ag

0.00
0.00 (0.00%)
- - Closed
Realtime Data
Share Name Share Symbol Market Type
Innosis Ecological Ag TG:IVX Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -

Product Launch

08/12/2003 1:50pm

UK Regulatory


    IVAX Corporation

IVAX Launches Amoxicillin With Clavulanate Potassium

IVAX Corporation (AMEX:IVX) (LSE:IVX.L) announced that its wholly
owned subsidiary, IVAX Pharmaceuticals, Inc. is distributing
amoxicillin with clavulanate potassium, supplied and licensed by
GlaxoSmithKline (LSE and NYSE:GSK). Amoxicillin with clavulnate
potassium is an oral antibacterial combination used for the treatment
of respiratory, urinary and skin infections; and is the generic
equivalent of Augmentin(R), which is marketed by GlaxoSmithKline. U.S.
sales for amoxicillin with clavulanate potassium were $1.4 billion for
the twelve months ending September 30, 2003.

IVAX Corporation, headquartered in Miami, Florida, discovers,
develops, manufactures, and markets branded and brand equivalent
(generic) pharmaceuticals and veterinary products in the U.S. and
internationally.

Copies of this and other news releases may be obtained free of
charge from IVAX' website at http://www.ivax.com.

1 Year Innosis Ecological Chart

1 Year Innosis Ecological Chart

1 Month Innosis Ecological Chart

1 Month Innosis Ecological Chart

Your Recent History

Delayed Upgrade Clock